Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients With Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439177/all/repview. Accessed 07 May 2024.
Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439177/all/repview. Accessed May 7, 2024.
Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439177/all/repview
Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients With Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack [Internet]. In: Cochrane Abstracts. [cited 2024 May 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439177/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack
ID - 439177
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439177/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -